| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | integrin binding | 1.12e-03 | 175 | 6 | 2 | GO:0005178 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 5.29e-04 | 124 | 6 | 2 | GO:0007229 | |
| GeneOntologyBiologicalProcess | angiogenesis | 7.45e-04 | 708 | 6 | 3 | GO:0001525 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 1.13e-03 | 817 | 6 | 3 | GO:0048514 | |
| GeneOntologyBiologicalProcess | epithelial to mesenchymal transition | 1.41e-03 | 203 | 6 | 2 | GO:0001837 | |
| GeneOntologyBiologicalProcess | blood vessel development | 1.64e-03 | 929 | 6 | 3 | GO:0001568 | |
| GeneOntologyBiologicalProcess | vasculature development | 1.86e-03 | 969 | 6 | 3 | GO:0001944 | |
| GeneOntologyBiologicalProcess | negative regulation of molecular function | 2.06e-03 | 1005 | 6 | 3 | GO:0044092 | |
| GeneOntologyBiologicalProcess | regeneration | 2.16e-03 | 252 | 6 | 2 | GO:0031099 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell migration | 2.46e-03 | 269 | 6 | 2 | GO:0010594 | |
| GeneOntologyBiologicalProcess | cell-matrix adhesion | 2.47e-03 | 270 | 6 | 2 | GO:0007160 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 2.58e-03 | 276 | 6 | 2 | GO:0007179 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | 2.61e-03 | 1090 | 6 | 3 | GO:0022603 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | 2.86e-03 | 1125 | 6 | 3 | GO:0035239 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 2.96e-03 | 296 | 6 | 2 | GO:0048762 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | 3.53e-03 | 1211 | 6 | 3 | GO:0030334 | |
| GeneOntologyBiologicalProcess | endothelial cell migration | 3.69e-03 | 331 | 6 | 2 | GO:0043542 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 3.80e-03 | 336 | 6 | 2 | GO:0071560 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 3.96e-03 | 343 | 6 | 2 | GO:0071559 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell migration | 3.98e-03 | 344 | 6 | 2 | GO:0010632 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | 4.14e-03 | 1280 | 6 | 3 | GO:2000145 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | 4.59e-03 | 1327 | 6 | 3 | GO:0040012 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 4.64e-03 | 372 | 6 | 2 | GO:0060485 | |
| GeneOntologyBiologicalProcess | tube development | 5.36e-03 | 1402 | 6 | 3 | GO:0035295 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 5.61e-03 | 410 | 6 | 2 | GO:0031589 | |
| GeneOntologyBiologicalProcess | circulatory system development | 5.81e-03 | 1442 | 6 | 3 | GO:0072359 | |
| GeneOntologyBiologicalProcess | negative regulation of cell migration | 5.85e-03 | 419 | 6 | 2 | GO:0030336 | |
| GeneOntologyBiologicalProcess | regulation of angiogenesis | 5.88e-03 | 420 | 6 | 2 | GO:0045765 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 6.04e-03 | 426 | 6 | 2 | GO:0043010 | |
| GeneOntologyBiologicalProcess | regulation of vasculature development | 6.15e-03 | 430 | 6 | 2 | GO:1901342 | |
| GeneOntologyBiologicalProcess | epithelial cell migration | 6.21e-03 | 432 | 6 | 2 | GO:0010631 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | 6.29e-03 | 1483 | 6 | 3 | GO:0048646 | |
| GeneOntologyBiologicalProcess | negative regulation of cell motility | 6.29e-03 | 435 | 6 | 2 | GO:2000146 | |
| GeneOntologyBiologicalProcess | epithelium migration | 6.29e-03 | 435 | 6 | 2 | GO:0090132 | |
| GeneOntologyBiologicalProcess | tissue migration | 6.46e-03 | 441 | 6 | 2 | GO:0090130 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 6.58e-03 | 445 | 6 | 2 | GO:0141091 | |
| GeneOntologyBiologicalProcess | negative regulation of locomotion | 6.84e-03 | 454 | 6 | 2 | GO:0040013 | |
| GeneOntologyBiologicalProcess | eye development | 7.62e-03 | 480 | 6 | 2 | GO:0001654 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 7.68e-03 | 482 | 6 | 2 | GO:0007178 | |
| GeneOntologyBiologicalProcess | visual system development | 7.71e-03 | 483 | 6 | 2 | GO:0150063 | |
| GeneOntologyBiologicalProcess | sensory system development | 7.96e-03 | 491 | 6 | 2 | GO:0048880 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | 1.09e-02 | 577 | 6 | 2 | GO:0001667 | |
| Domain | EGF_extracell | 1.51e-04 | 60 | 6 | 2 | IPR013111 | |
| Domain | EGF_2 | 1.51e-04 | 60 | 6 | 2 | PF07974 | |
| Domain | EGF | 2.29e-03 | 235 | 6 | 2 | SM00181 | |
| Domain | EGF_1 | 2.69e-03 | 255 | 6 | 2 | PS00022 | |
| Domain | EGF-like_CS | 2.81e-03 | 261 | 6 | 2 | IPR013032 | |
| Domain | EGF_2 | 2.90e-03 | 265 | 6 | 2 | PS01186 | |
| Domain | - | 6.20e-03 | 391 | 6 | 2 | 2.30.29.30 | |
| Domain | PH_dom-like | 7.33e-03 | 426 | 6 | 2 | IPR011993 | |
| Pathway | KEGG_REGULATION_OF_ACTIN_CYTOSKELETON | 2.21e-03 | 213 | 5 | 2 | M18306 | |
| Pubmed | 2.04e-06 | 164 | 6 | 3 | 32409323 | ||
| Pubmed | 4.98e-05 | 64 | 6 | 2 | 36369321 | ||
| Interaction | ST8SIA5 interactions | 8.63e-05 | 49 | 6 | 2 | int:ST8SIA5 | |
| Interaction | ADAM33 interactions | 2.25e-04 | 79 | 6 | 2 | int:ADAM33 | |
| Interaction | MAPK1 interactions | 3.66e-04 | 543 | 6 | 3 | int:MAPK1 | |
| Interaction | SH3RF1 interactions | 4.21e-04 | 108 | 6 | 2 | int:SH3RF1 | |
| Interaction | ADAM9 interactions | 5.11e-04 | 119 | 6 | 2 | int:ADAM9 | |
| Interaction | PALLD interactions | 5.45e-04 | 123 | 6 | 2 | int:PALLD | |
| Interaction | SH3PXD2A interactions | 5.90e-04 | 128 | 6 | 2 | int:SH3PXD2A | |
| Interaction | ECEL1 interactions | 6.47e-04 | 134 | 6 | 2 | int:ECEL1 | |
| Interaction | CST1 interactions | 7.16e-04 | 141 | 6 | 2 | int:CST1 | |
| Interaction | ZNF408 interactions | 7.57e-04 | 145 | 6 | 2 | int:ZNF408 | |
| Interaction | CLEC2B interactions | 7.78e-04 | 147 | 6 | 2 | int:CLEC2B | |
| Interaction | FBXO6 interactions | 8.28e-04 | 717 | 6 | 3 | int:FBXO6 | |
| Interaction | SLX9 interactions | 1.12e-03 | 177 | 6 | 2 | int:SLX9 | |
| Interaction | ZNF655 interactions | 1.18e-03 | 181 | 6 | 2 | int:ZNF655 | |
| Interaction | BRICD5 interactions | 1.35e-03 | 194 | 6 | 2 | int:BRICD5 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_DN | 4.68e-04 | 148 | 6 | 2 | M40921 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | 5.19e-04 | 795 | 6 | 3 | M39050 | |
| Coexpression | BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN | 5.47e-04 | 160 | 6 | 2 | M9556 | |
| Coexpression | BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN | 6.53e-04 | 175 | 6 | 2 | M34029 | |
| Coexpression | FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN | 6.99e-04 | 181 | 6 | 2 | M40912 | |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_UP | 8.35e-04 | 198 | 6 | 2 | M8730 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_UP | 8.43e-04 | 199 | 6 | 2 | M8734 | |
| Coexpression | GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP | 8.43e-04 | 199 | 6 | 2 | M5620 | |
| Coexpression | GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_DN | 8.52e-04 | 200 | 6 | 2 | M7083 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN | 8.52e-04 | 200 | 6 | 2 | M4612 | |
| Coexpression | GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN | 8.52e-04 | 200 | 6 | 2 | M5286 | |
| Coexpression | GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_UP | 8.52e-04 | 200 | 6 | 2 | M3793 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_DN | 8.52e-04 | 200 | 6 | 2 | M6639 | |
| Coexpression | GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_UP | 8.52e-04 | 200 | 6 | 2 | M7198 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_UP | 8.52e-04 | 200 | 6 | 2 | M3834 | |
| Coexpression | GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_UP | 8.52e-04 | 200 | 6 | 2 | M8433 | |
| Coexpression | GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP | 8.52e-04 | 200 | 6 | 2 | M5154 | |
| Coexpression | GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_DN | 8.52e-04 | 200 | 6 | 2 | M8218 | |
| Coexpression | GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_UP | 8.52e-04 | 200 | 6 | 2 | M8209 | |
| Coexpression | GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP | 8.52e-04 | 200 | 6 | 2 | M6057 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP | 8.52e-04 | 200 | 6 | 2 | M5229 | |
| Coexpression | GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP | 8.52e-04 | 200 | 6 | 2 | M7424 | |
| Coexpression | GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN | 8.52e-04 | 200 | 6 | 2 | M7668 | |
| Coexpression | GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP | 8.52e-04 | 200 | 6 | 2 | M7433 | |
| Coexpression | GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP | 8.52e-04 | 200 | 6 | 2 | M5617 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | 8.60e-04 | 201 | 6 | 2 | M1571 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | 1.14e-03 | 232 | 6 | 2 | MM1019 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 1.17e-03 | 235 | 6 | 2 | M5311 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II+.Bl, CD115+ B220- CD43+ Ly6C+ MHCIIint, Blood, avg-4 | 1.95e-06 | 408 | 6 | 4 | GSM605868_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.BM, B220neg CD3neg CD115+ Ly-6C+, Bone marrow, avg-3 | 1.19e-04 | 391 | 6 | 3 | GSM854329_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Lv, CD45+ F4/80+ CD11b+, Liver, avg-2 | 1.29e-04 | 402 | 6 | 3 | GSM854320_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Microglia.CNS, CD45low CD11b+ F4/80+, Brain, avg-3 | 1.33e-04 | 406 | 6 | 3 | GSM854326_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.Bl, Cd115+ B220- CD43+ Ly6C+ MHCII-, Blood, avg-3 | 1.38e-04 | 411 | 6 | 3 | GSM605872_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C-II+.Bl, CD115+ B220- CD43+ Ly6C- MHCIIhi, Blood, avg-2 | 1.40e-04 | 413 | 6 | 3 | GSM605878_500 | |
| CoexpressionAtlas | Myeloid Cells, DC.103-11b+24-.Lu, MHCII+ CD11c+ CD103- CD11b+ CD24-, Lung, avg-2 | 1.41e-04 | 414 | 6 | 3 | GSM854271_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480lo.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 1.53e-04 | 426 | 6 | 3 | GSM605859_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 1.61e-04 | 433 | 6 | 3 | GSM605856_500 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 1.45e-06 | 189 | 6 | 3 | aac79c41ce7acba722c45c016b2c6997fb772a96 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.59e-06 | 195 | 6 | 3 | c16479a10f5ca2e89aea1742dbc5cc4dc9f3ea88 | |
| ToppCell | Monocytes-M2-like_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.59e-06 | 195 | 6 | 3 | 10fa47bdcf6c9784ea930b75a5861e139421feed | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.61e-06 | 196 | 6 | 3 | e0447ad2efb021b63c7fef000d39b6b21fbe6113 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.61e-06 | 196 | 6 | 3 | 3bca88eede3dd7368715ced02e3bacd1e3e82cab | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.69e-06 | 199 | 6 | 3 | 980b10b81ee9dc952e3be25bd294201ce5a4ca8b | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.69e-06 | 199 | 6 | 3 | cbd423c31d75f6d2f5ae85d2241641fcbe630b81 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.69e-06 | 199 | 6 | 3 | c0dcdda30485bb920d3706dcfb06f11b76b6ea37 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.69e-06 | 199 | 6 | 3 | b827dd8a249f904a0ff930a6c4d3b00fb7bc6fb1 | |
| ToppCell | Sigmoid-(6)_Macrophage-(61)_LYVE1_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 1.71e-06 | 200 | 6 | 3 | bc0280d52e4edc2c5edf4ead164a1c7cf3fccd60 | |
| ToppCell | Sigmoid-Macrophage-LYVE1_Macrophage|Sigmoid / Region, Cell class and subclass | 1.71e-06 | 200 | 6 | 3 | 851a1b372ddbec522829069e69ed36a1f4832131 | |
| ToppCell | Sigmoid-(6)_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 1.71e-06 | 200 | 6 | 3 | 9e10cca4429de2c4c8c3c6cf2c9e28637a095be9 | |
| ToppCell | Sigmoid-Macrophage|Sigmoid / Region, Cell class and subclass | 1.71e-06 | 200 | 6 | 3 | b07ac0ff3b8530e99094678fed80f35949cafac8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.14e-05 | 84 | 6 | 2 | 9ffce86c3491a464fbec9b9e5e6e7b7cc28afa88 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 1.78e-04 | 156 | 6 | 2 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_3|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-04 | 162 | 6 | 2 | 0acb8f7b51bf422d4f4f8e99bd10360163ae4eb7 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.96e-04 | 164 | 6 | 2 | 057ca87847373eff7fe97dd9f4358509e66ca4c3 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 168 | 6 | 2 | f3b7a7df54988de77dcc7066e2fc1feb9c280b13 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 169 | 6 | 2 | 44d841fd997a6f26104f16cd00223ecce8352f43 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 169 | 6 | 2 | 0f5e737b265ba333275a0cd289dab029a1542075 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 169 | 6 | 2 | aec1b4c7e973a31c53aaea47c2c05d24ce16aa4f | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.08e-04 | 169 | 6 | 2 | 2c851b2703c7b8b656026f996f5fc027e4a79b36 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 169 | 6 | 2 | 91cfff1ad559cc327c6bb71c98aa29f0b3642568 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 169 | 6 | 2 | 972618e684321060c7af2429f853a6d639e8aae8 | |
| ToppCell | droplet-Spleen-nan-3m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 169 | 6 | 2 | 8e5e513090e86ca29fb61dfd388014774c506914 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 170 | 6 | 2 | 7cb7ad9ab064b6ea452545d145e5b1d4090cd4c1 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.11e-04 | 170 | 6 | 2 | db7cee7e518debb2cbe9eeae05d47e14b69cb8e3 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-04 | 171 | 6 | 2 | 35acc5c3e36bc605603c0d45375f2cf3c3e9d4cd | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 173 | 6 | 2 | 807183fc23478da9451906dacd88de4e73112e0d | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 173 | 6 | 2 | 2e683ec555dc0036875e0f5674dcc5e93ead205d | |
| ToppCell | Immune_cells-Monocytes|Immune_cells / Lineage and Cell class | 2.18e-04 | 173 | 6 | 2 | 3eced40a65453a023a1673658592e7e2a099119b | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 173 | 6 | 2 | 9ba55e21d1037ec3150d77895e52f0b051df65da | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-04 | 174 | 6 | 2 | 0a8fa44604be19fbac722ebc6d1cd72b71be7022 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 174 | 6 | 2 | 3533a47885af453d97739e5576e989d93d31be32 | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Mac-Intestinal_macrophages|bone_marrow / Manually curated celltypes from each tissue | 2.21e-04 | 174 | 6 | 2 | 0746344d62aa7ab77c378e9d5a9f9238e741a76b | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 174 | 6 | 2 | dc4298c1d9359f7e37454e9451f889017227d5cf | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 174 | 6 | 2 | b487c5c46f074a69b9526a2c72daf218f66aa44b | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-04 | 175 | 6 | 2 | 92a4a3fd323ee8360edd659f9e16dfddc8788e2f | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.23e-04 | 175 | 6 | 2 | 1973fff0d7e1a94b31f461a39b91cc7984ebd8f1 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.23e-04 | 175 | 6 | 2 | 53e6f1f8dd482dfa2539e068dacefbb6e08443bc | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-04 | 176 | 6 | 2 | 1e430dffddd315d9a1cb4bd7fef5077656351c65 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.28e-04 | 177 | 6 | 2 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.31e-04 | 178 | 6 | 2 | 536a601abcc60867949ea06e9aafb6c7b799b56b | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac-Macrophage|bone_marrow / Manually curated celltypes from each tissue | 2.31e-04 | 178 | 6 | 2 | 11a338032b59b936c5e65517c4160f7dd47a2cda | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Nonclassical_Monocyte|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.34e-04 | 179 | 6 | 2 | 6624a2e731ab2d6c2eec19445e3dc509f581a8a9 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.36e-04 | 180 | 6 | 2 | b94618c1c2592ecf7da3535294aee9243755247a | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-IM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.36e-04 | 180 | 6 | 2 | a600bc705993d3a010550a25d3b54358946f061f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.36e-04 | 180 | 6 | 2 | 2bc3fd2e4c249bf236340c5f0483747faa5c04ec | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.39e-04 | 181 | 6 | 2 | 1b4eb044825ede6361928442524b1988c8ef58b3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Myeloid-Dendritic|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.39e-04 | 181 | 6 | 2 | 8d7ebbedc373d55e29da02ac2728b4f4118038f2 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.39e-04 | 181 | 6 | 2 | a8d4b2340d99734bf9379b467fb481c598b9b4fb | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.39e-04 | 181 | 6 | 2 | a93df1ba23d5b5f249491d69d12bfc0e274dafcf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.42e-04 | 182 | 6 | 2 | d57d18732aa6fb7b2d430601568f9ba525ac6e3c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.42e-04 | 182 | 6 | 2 | 9a68d3bd1cc9139de9e9e711c249d47ade826bb1 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Mac|bone_marrow / Manually curated celltypes from each tissue | 2.42e-04 | 182 | 6 | 2 | e1d6b5de5bd1d11e968da3a55e5326ef252f55ba | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.42e-04 | 182 | 6 | 2 | c3fb1460160744144aa31afc76c0a4d42ebdeb91 | |
| ToppCell | 18-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 2.44e-04 | 183 | 6 | 2 | a75cda2131755931117c387f2e0ae3394efa8e80 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.44e-04 | 183 | 6 | 2 | 745271bfe15e94a58157cd97d771e610f964341b | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Macrophage|lymph-node_spleen / Manually curated celltypes from each tissue | 2.44e-04 | 183 | 6 | 2 | 0bcbd60e10b9d6898915dab1987fd46dc7238b19 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Monocytic-Cycling_mono|bone_marrow / Manually curated celltypes from each tissue | 2.44e-04 | 183 | 6 | 2 | f10e72a2e2e6cdc1984f469a60244e5fd8a10095 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.47e-04 | 184 | 6 | 2 | 5535b85b3ad3d0c0392d5884fdc2939c7e1b1c3e | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.47e-04 | 184 | 6 | 2 | 9d678b24532b7763f2e73f7ccb496259977c5204 | |
| ToppCell | PBMC-Convalescent-Myeloid-cDC-cDC-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.47e-04 | 184 | 6 | 2 | 383374ad17bd322b8d703a22e475d34ca7b2e6b6 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.47e-04 | 184 | 6 | 2 | e343dd7777a29048e3f12a939f7f782b8b7b4fea | |
| ToppCell | COVID-19_Convalescent-Myeloid-cDC|COVID-19_Convalescent / Disease group, lineage and cell class | 2.47e-04 | 184 | 6 | 2 | ad6e910eaebe841a68a5f2f329d43dafc5db158a | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.50e-04 | 185 | 6 | 2 | d4ba36bdb8b7e3a62e827269484f89f790eaa5ef | |
| ToppCell | facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-04 | 186 | 6 | 2 | a7ab70b049742dfe7ee30557031bfac6412edf52 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Erythrophagocytic_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 2.52e-04 | 186 | 6 | 2 | a0cc925af97e47efd0c9bc17c37963e8ad4e5b35 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-04 | 187 | 6 | 2 | 7b24a324335c30c4b37795c43611b297274c804b | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-DC2|blood / Manually curated celltypes from each tissue | 2.55e-04 | 187 | 6 | 2 | ab9c9930341527122f26fe5544c5c4818d1fd1b5 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-mo-Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 2.58e-04 | 188 | 6 | 2 | e83de94a9b47a6a90e98face887eae031a322af6 | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic|GI_large-bowel / Manually curated celltypes from each tissue | 2.58e-04 | 188 | 6 | 2 | d0045fdda757d191dabc7853f6a6e99c0e97d93d | |
| ToppCell | 10x5'-GI_large-bowel-Myeloid_Monocytic-Classical_monocytes|GI_large-bowel / Manually curated celltypes from each tissue | 2.58e-04 | 188 | 6 | 2 | 0bcf04aa47738f43c1a87dae5dc487738ee86f8c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-04 | 189 | 6 | 2 | 12b6f1c3bf526b90e112374bf937701f645c5780 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Mac-Erythrophagocytic_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue | 2.63e-04 | 190 | 6 | 2 | 96c6078619e85f630c9754aca5d6066433e22836 | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-04 | 190 | 6 | 2 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | droplet-Marrow-nan-18m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.63e-04 | 190 | 6 | 2 | 95d8dc8488e95158e84a44bb53ea4ab7bf3d44bb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.63e-04 | 190 | 6 | 2 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.63e-04 | 190 | 6 | 2 | 0a944da2aaaef9289b2a4ffe360b0338724fd59b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.63e-04 | 190 | 6 | 2 | 4b9bac17eb7ceadada932f2d4a20a5f176088d53 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.66e-04 | 191 | 6 | 2 | 4cebaf31d4f09f4ab273a819ad5cbff7d9a9b341 | |
| ToppCell | facs-Brain_Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-04 | 191 | 6 | 2 | bf1135b382a3bf8cddc19538bc38361ef1fc2de1 | |
| ToppCell | (01)_Dendritic_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 2.66e-04 | 191 | 6 | 2 | 1f4c8078e1a6cd14937c714330af608caced2acf | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.66e-04 | 191 | 6 | 2 | 51535232e889db52a9b24e5696b1687e93dd7302 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.66e-04 | 191 | 6 | 2 | be2fe2583bdcee0b35c43a347da9c4adb93e30e0 | |
| ToppCell | Control-B_intermediate-10|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.69e-04 | 192 | 6 | 2 | 224bd958369ba8fa0d7be2126f7dc61c9f6ac19d | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.72e-04 | 193 | 6 | 2 | 93ba635ed69fec9286fe7636b9d258f3d93a22c3 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.72e-04 | 193 | 6 | 2 | b18c61e360f5f094f260007a56b189e2a48369e4 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.72e-04 | 193 | 6 | 2 | 6dfdeb793cb5ad6412b6f808b5687a4e74b6ec65 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.72e-04 | 193 | 6 | 2 | 6b3a2a32ec6dc96230cee4bbf03932f8a81e6683 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-04 | 193 | 6 | 2 | 33437fdb417d78463caee14a9f0e094da1733829 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.74e-04 | 194 | 6 | 2 | e3688f4252aae5f849f025d7f453ff4c0c14590b | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.74e-04 | 194 | 6 | 2 | e0cfd18a7ea2251163d61312b9397f8a518c8c51 | |
| ToppCell | BAL-Mild-Myeloid-MoAM-MoAM3-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.74e-04 | 194 | 6 | 2 | e455cb469157c044126f9b0b308957d4ee1e608b | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.74e-04 | 194 | 6 | 2 | 8e2819a9d0529f7b2de1a7c1190575175d6173ee | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.74e-04 | 194 | 6 | 2 | ad72be9f6871b334e1f477d868c15e7792fadea5 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.74e-04 | 194 | 6 | 2 | 449ce4167d64c170d914e0250f739eabedcf915d | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 2.74e-04 | 194 | 6 | 2 | 8dcde77767b23e75360adb316cdccf56a00e3726 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.77e-04 | 195 | 6 | 2 | becad890a420267ca41e98e61a8da343b51e1945 | |
| ToppCell | 390C-Myeloid-Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-04 | 195 | 6 | 2 | ba494be431916d43c1d480f65bed674c0722c710 | |
| Computational | Genes in the cancer module 3. | 3.73e-03 | 384 | 3 | 2 | MODULE_3 | |
| Computational | cell line expressed genes. | 4.22e-03 | 409 | 3 | 2 | MODULE_118 | |
| Computational | Trachea genes. | 4.35e-03 | 415 | 3 | 2 | MODULE_6 | |
| Computational | Heart genes. | 4.51e-03 | 423 | 3 | 2 | MODULE_60 | |
| Computational | Cell line expressed genes. | 4.71e-03 | 432 | 3 | 2 | MODULE_52 | |
| Computational | Lung genes. | 4.75e-03 | 434 | 3 | 2 | MODULE_5 | |
| Computational | Placenta genes. | 5.40e-03 | 463 | 3 | 2 | MODULE_38 | |
| Drug | Oxamniquine [21738-42-1]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.14e-05 | 191 | 6 | 3 | 4124_DN | |
| Drug | Rgd Peptide | 2.23e-05 | 239 | 6 | 3 | CID000104802 | |
| Drug | 3-(phosphonomethyl)pyridine-2-carboxylic acid | 1.86e-04 | 81 | 6 | 2 | CID000001629 | |
| Drug | didox | 1.95e-04 | 83 | 6 | 2 | CID000003045 | |
| Drug | retinoic acid; Up 200; 1uM; HL60; HT_HG-U133A | 5.94e-04 | 145 | 6 | 2 | 1152_UP | |
| Drug | Retinoic acid [302-79-4]; Up 200; 13.4uM; HL60; HG-U133A | 7.50e-04 | 163 | 6 | 2 | 1548_UP | |
| Drug | 1pzj | 7.87e-04 | 167 | 6 | 2 | CID000447976 | |
| Drug | Piribedil hydrochloride [78213-63-5]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.03e-03 | 191 | 6 | 2 | 5434_DN | |
| Drug | Leucomisine [17946-87-1]; Down 200; 16.2uM; PC3; HT_HG-U133A | 1.06e-03 | 194 | 6 | 2 | 7125_DN | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 1.07e-03 | 195 | 6 | 2 | 1522_DN | |
| Drug | rotenone; Up 200; 1uM; MCF7; HT_HG-U133A | 1.07e-03 | 195 | 6 | 2 | 5943_UP | |
| Drug | Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.07e-03 | 195 | 6 | 2 | 1523_DN | |
| Drug | Benzthiazide [91-33-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 3329_DN | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 7184_UP | |
| Drug | Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 4421_UP | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; HL60; HG-U133A | 1.08e-03 | 196 | 6 | 2 | 1738_UP | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 3420_UP | |
| Drug | Kynurenine, 3-hydroxy (R,S) [2147-61-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 5276_DN | |
| Drug | Pizotifen malate [5189-11-7]; Down 200; 9.4uM; PC3; HT_HG-U133A | 1.08e-03 | 196 | 6 | 2 | 5072_DN | |
| Drug | Convolamine hydrochloride [500-56-1]; Up 200; 11.8uM; HL60; HG-U133A | 1.09e-03 | 197 | 6 | 2 | 1779_UP | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; HL60; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 2176_DN | |
| Drug | Fusidic acid sodium salt [751-94-0]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 5353_UP | |
| Drug | Picrotoxinin [17617-45-7]; Up 200; 13.6uM; HL60; HT_HG-U133A | 1.09e-03 | 197 | 6 | 2 | 2161_UP | |
| Drug | Harmol hydrochloride monohydrate [40580-83-4]; Up 200; 15.8uM; HL60; HG-U133A | 1.09e-03 | 197 | 6 | 2 | 1750_UP | |
| Drug | Amoxapine [14028-44-5]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 1513_DN | |
| Drug | Methyldopa (L,-) [555-30-6]; Down 200; 19uM; MCF7; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 5272_DN | |
| Drug | Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.10e-03 | 198 | 6 | 2 | 1831_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 5295_DN | |
| Drug | Clonidine hydrochloride [4205-91-8]; Down 200; 15uM; MCF7; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 6814_DN | |
| Drug | Thiocolchicoside [602-41-5]; Down 200; 7uM; PC3; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 5095_DN | |
| Drug | Debrisoquin sulfate [581-88-4]; Down 200; 9uM; MCF7; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 5288_DN | |
| Drug | Azaperone [1649-18-9]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 7231_UP | |
| Drug | Diphenylpyraline hydrochloride [132-18-3]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.11e-03 | 199 | 6 | 2 | 3640_DN | |
| Drug | Cefoxitin sodium salt [33564-30-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.13e-03 | 200 | 6 | 2 | 3477_DN | |
| Drug | haloperidol; Up 200; 10uM; HL60; HT_HG-U133A | 1.13e-03 | 200 | 6 | 2 | 1144_UP | |
| Disease | Congenital neurologic anomalies | 1.55e-06 | 10 | 6 | 2 | C0497552 | |
| Disease | Cranioschisis | 1.55e-06 | 10 | 6 | 2 | C0265541 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CQCCYDCHAGIHGEA | 301 | Q96N23 | |
| CHGHGVCDSNRHCYC | 661 | Q13444 | |
| ACGDGHHCCPRGFHC | 91 | P28799 | |
| VLCSGHGECHCGECK | 561 | P18084 | |
| HGECHCGECKCHAGY | 566 | P18084 | |
| HHCKACGHVVCGKCS | 751 | P98174 | |
| CHRCGEACGCCGGKH | 426 | Q7Z699 |